biofire pneumonia panel Search Results


pneumonia panel  (BioFire Defense)
90
BioFire Defense pneumonia panel
Pneumonia Panel, supplied by BioFire Defense, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/pneumonia panel/product/BioFire Defense
Average 90 stars, based on 1 article reviews
pneumonia panel - by Bioz Stars, 2026-06
90/100 stars
  Buy from Supplier
biofire pneumonia panel  (BioFire Defense)
90
BioFire Defense biofire pneumonia panel
Biofire Pneumonia Panel, supplied by BioFire Defense, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/biofire pneumonia panel/product/BioFire Defense
Average 90 stars, based on 1 article reviews
biofire pneumonia panel - by Bioz Stars, 2026-06
90/100 stars
  Buy from Supplier
filmarray pneumonia panel  (BioFire Defense)
90
BioFire Defense filmarray pneumonia panel
Filmarray Pneumonia Panel, supplied by BioFire Defense, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/filmarray pneumonia panel/product/BioFire Defense
Average 90 stars, based on 1 article reviews
filmarray pneumonia panel - by Bioz Stars, 2026-06
90/100 stars
  Buy from Supplier
filmarray pneumonia (pn) panel  (BioFire Diagnostics)
90
BioFire Diagnostics filmarray pneumonia (pn) panel
Filmarray Pneumonia (Pn) Panel, supplied by BioFire Diagnostics, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/filmarray pneumonia (pn) panel/product/BioFire Diagnostics
Average 90 stars, based on 1 article reviews
filmarray pneumonia (pn) panel - by Bioz Stars, 2026-06
90/100 stars
  Buy from Supplier
fap plus - filmarray® pneumonia plus panel  (BioFire Defense)
90
BioFire Defense fap plus - filmarray® pneumonia plus panel
Fap Plus Filmarray® Pneumonia Plus Panel, supplied by BioFire Defense, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/fap plus - filmarray® pneumonia plus panel/product/BioFire Defense
Average 90 stars, based on 1 article reviews
fap plus - filmarray® pneumonia plus panel - by Bioz Stars, 2026-06
90/100 stars
  Buy from Supplier
broad-panel respiratory mpcr filmarray pneumonia panel plus  (BioFire Defense)
90
BioFire Defense broad-panel respiratory mpcr filmarray pneumonia panel plus
Trial design. In the intervention arm, before the end of day 1, clinicians have to consider all the early microbiological results <t>(mPCR</t> FA-PPP, urine antigen assays, blood cultures and Gram stain examination of <t>respiratory</t> tract sample) and procalcitonin before the end of day 1, and subsequently to apply an algorithm of early antibiotics discontinuation or de-escalation (red square). This algorithm is described in . In both arms, at day 3 and day after day until day 7, clinicians are encouraged to consider antibiotic discontinuation, based on procalcitonin values and kinetics. CAP, community-acquired pneumonia; FA-PPP, FilmArray Pneumonia Panel Plus; ICU, intensive care unit; mPCR, multiplex PCR.
Broad Panel Respiratory Mpcr Filmarray Pneumonia Panel Plus, supplied by BioFire Defense, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/broad-panel respiratory mpcr filmarray pneumonia panel plus/product/BioFire Defense
Average 90 stars, based on 1 article reviews
broad-panel respiratory mpcr filmarray pneumonia panel plus - by Bioz Stars, 2026-06
90/100 stars
  Buy from Supplier
biofire filmarray pneumonia panel  (BioFire Diagnostics)
90
BioFire Diagnostics biofire filmarray pneumonia panel
Trial design. In the intervention arm, before the end of day 1, clinicians have to consider all the early microbiological results <t>(mPCR</t> FA-PPP, urine antigen assays, blood cultures and Gram stain examination of <t>respiratory</t> tract sample) and procalcitonin before the end of day 1, and subsequently to apply an algorithm of early antibiotics discontinuation or de-escalation (red square). This algorithm is described in . In both arms, at day 3 and day after day until day 7, clinicians are encouraged to consider antibiotic discontinuation, based on procalcitonin values and kinetics. CAP, community-acquired pneumonia; FA-PPP, FilmArray Pneumonia Panel Plus; ICU, intensive care unit; mPCR, multiplex PCR.
Biofire Filmarray Pneumonia Panel, supplied by BioFire Diagnostics, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/biofire filmarray pneumonia panel/product/BioFire Diagnostics
Average 90 stars, based on 1 article reviews
biofire filmarray pneumonia panel - by Bioz Stars, 2026-06
90/100 stars
  Buy from Supplier
pneumonia panel  (BioFire Diagnostics)
90
BioFire Diagnostics pneumonia panel
Trial design. In the intervention arm, before the end of day 1, clinicians have to consider all the early microbiological results <t>(mPCR</t> FA-PPP, urine antigen assays, blood cultures and Gram stain examination of <t>respiratory</t> tract sample) and procalcitonin before the end of day 1, and subsequently to apply an algorithm of early antibiotics discontinuation or de-escalation (red square). This algorithm is described in . In both arms, at day 3 and day after day until day 7, clinicians are encouraged to consider antibiotic discontinuation, based on procalcitonin values and kinetics. CAP, community-acquired pneumonia; FA-PPP, FilmArray Pneumonia Panel Plus; ICU, intensive care unit; mPCR, multiplex PCR.
Pneumonia Panel, supplied by BioFire Diagnostics, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/pneumonia panel/product/BioFire Diagnostics
Average 90 stars, based on 1 article reviews
pneumonia panel - by Bioz Stars, 2026-06
90/100 stars
  Buy from Supplier
pneumonia panel filamarray  (BioFire Defense)
90
BioFire Defense pneumonia panel filamarray
Trial design. In the intervention arm, before the end of day 1, clinicians have to consider all the early microbiological results <t>(mPCR</t> FA-PPP, urine antigen assays, blood cultures and Gram stain examination of <t>respiratory</t> tract sample) and procalcitonin before the end of day 1, and subsequently to apply an algorithm of early antibiotics discontinuation or de-escalation (red square). This algorithm is described in . In both arms, at day 3 and day after day until day 7, clinicians are encouraged to consider antibiotic discontinuation, based on procalcitonin values and kinetics. CAP, community-acquired pneumonia; FA-PPP, FilmArray Pneumonia Panel Plus; ICU, intensive care unit; mPCR, multiplex PCR.
Pneumonia Panel Filamarray, supplied by BioFire Defense, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/pneumonia panel filamarray/product/BioFire Defense
Average 90 stars, based on 1 article reviews
pneumonia panel filamarray - by Bioz Stars, 2026-06
90/100 stars
  Buy from Supplier
386 pneumonia panel  (BioFire Defense)
90
BioFire Defense 386 pneumonia panel
Trial design. In the intervention arm, before the end of day 1, clinicians have to consider all the early microbiological results <t>(mPCR</t> FA-PPP, urine antigen assays, blood cultures and Gram stain examination of <t>respiratory</t> tract sample) and procalcitonin before the end of day 1, and subsequently to apply an algorithm of early antibiotics discontinuation or de-escalation (red square). This algorithm is described in . In both arms, at day 3 and day after day until day 7, clinicians are encouraged to consider antibiotic discontinuation, based on procalcitonin values and kinetics. CAP, community-acquired pneumonia; FA-PPP, FilmArray Pneumonia Panel Plus; ICU, intensive care unit; mPCR, multiplex PCR.
386 Pneumonia Panel, supplied by BioFire Defense, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/386 pneumonia panel/product/BioFire Defense
Average 90 stars, based on 1 article reviews
386 pneumonia panel - by Bioz Stars, 2026-06
90/100 stars
  Buy from Supplier
filmaarray pneumonia plus-ivd panel  (BioFire Defense)
90
BioFire Defense filmaarray pneumonia plus-ivd panel
Trial design. In the intervention arm, before the end of day 1, clinicians have to consider all the early microbiological results <t>(mPCR</t> FA-PPP, urine antigen assays, blood cultures and Gram stain examination of <t>respiratory</t> tract sample) and procalcitonin before the end of day 1, and subsequently to apply an algorithm of early antibiotics discontinuation or de-escalation (red square). This algorithm is described in . In both arms, at day 3 and day after day until day 7, clinicians are encouraged to consider antibiotic discontinuation, based on procalcitonin values and kinetics. CAP, community-acquired pneumonia; FA-PPP, FilmArray Pneumonia Panel Plus; ICU, intensive care unit; mPCR, multiplex PCR.
Filmaarray Pneumonia Plus Ivd Panel, supplied by BioFire Defense, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/filmaarray pneumonia plus-ivd panel/product/BioFire Defense
Average 90 stars, based on 1 article reviews
filmaarray pneumonia plus-ivd panel - by Bioz Stars, 2026-06
90/100 stars
  Buy from Supplier
fa pneumonia panel  (BioFire Diagnostics)
90
BioFire Diagnostics fa pneumonia panel
Trial design. In the intervention arm, before the end of day 1, clinicians have to consider all the early microbiological results <t>(mPCR</t> FA-PPP, urine antigen assays, blood cultures and Gram stain examination of <t>respiratory</t> tract sample) and procalcitonin before the end of day 1, and subsequently to apply an algorithm of early antibiotics discontinuation or de-escalation (red square). This algorithm is described in . In both arms, at day 3 and day after day until day 7, clinicians are encouraged to consider antibiotic discontinuation, based on procalcitonin values and kinetics. CAP, community-acquired pneumonia; FA-PPP, FilmArray Pneumonia Panel Plus; ICU, intensive care unit; mPCR, multiplex PCR.
Fa Pneumonia Panel, supplied by BioFire Diagnostics, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/fa pneumonia panel/product/BioFire Diagnostics
Average 90 stars, based on 1 article reviews
fa pneumonia panel - by Bioz Stars, 2026-06
90/100 stars
  Buy from Supplier

Image Search Results


Trial design. In the intervention arm, before the end of day 1, clinicians have to consider all the early microbiological results (mPCR FA-PPP, urine antigen assays, blood cultures and Gram stain examination of respiratory tract sample) and procalcitonin before the end of day 1, and subsequently to apply an algorithm of early antibiotics discontinuation or de-escalation (red square). This algorithm is described in . In both arms, at day 3 and day after day until day 7, clinicians are encouraged to consider antibiotic discontinuation, based on procalcitonin values and kinetics. CAP, community-acquired pneumonia; FA-PPP, FilmArray Pneumonia Panel Plus; ICU, intensive care unit; mPCR, multiplex PCR.

Journal: BMJ Open

Article Title: Combined use of a broad-panel respiratory multiplex PCR and procalcitonin to reduce duration of antibiotics exposure in patients with severe community-acquired pneumonia (MULTI-CAP): a multicentre, parallel-group, open-label, individual randomised trial conducted in French intensive care units

doi: 10.1136/bmjopen-2020-048187

Figure Lengend Snippet: Trial design. In the intervention arm, before the end of day 1, clinicians have to consider all the early microbiological results (mPCR FA-PPP, urine antigen assays, blood cultures and Gram stain examination of respiratory tract sample) and procalcitonin before the end of day 1, and subsequently to apply an algorithm of early antibiotics discontinuation or de-escalation (red square). This algorithm is described in . In both arms, at day 3 and day after day until day 7, clinicians are encouraged to consider antibiotic discontinuation, based on procalcitonin values and kinetics. CAP, community-acquired pneumonia; FA-PPP, FilmArray Pneumonia Panel Plus; ICU, intensive care unit; mPCR, multiplex PCR.

Article Snippet: In the experimental strategy arm, the microbiological diagnosis combines a broad-panel respiratory mPCR (FilmArray Pneumonia Panel Plus (FA-PPP), BioFire Biomérieux) with conventional microbiological investigations.

Techniques: Staining, Multiplex Assay

Algorithm of early antibiotics de-escalation or discontinuation. The algorithm is applied in the intervention arm only (see red square, ). mPCR, multiplex PCR; ICU, intensive care unit; PCT, procalcitonin.

Journal: BMJ Open

Article Title: Combined use of a broad-panel respiratory multiplex PCR and procalcitonin to reduce duration of antibiotics exposure in patients with severe community-acquired pneumonia (MULTI-CAP): a multicentre, parallel-group, open-label, individual randomised trial conducted in French intensive care units

doi: 10.1136/bmjopen-2020-048187

Figure Lengend Snippet: Algorithm of early antibiotics de-escalation or discontinuation. The algorithm is applied in the intervention arm only (see red square, ). mPCR, multiplex PCR; ICU, intensive care unit; PCT, procalcitonin.

Article Snippet: In the experimental strategy arm, the microbiological diagnosis combines a broad-panel respiratory mPCR (FilmArray Pneumonia Panel Plus (FA-PPP), BioFire Biomérieux) with conventional microbiological investigations.

Techniques: Multiplex Assay

Primary and secondary outcomes

Journal: BMJ Open

Article Title: Combined use of a broad-panel respiratory multiplex PCR and procalcitonin to reduce duration of antibiotics exposure in patients with severe community-acquired pneumonia (MULTI-CAP): a multicentre, parallel-group, open-label, individual randomised trial conducted in French intensive care units

doi: 10.1136/bmjopen-2020-048187

Figure Lengend Snippet: Primary and secondary outcomes

Article Snippet: In the experimental strategy arm, the microbiological diagnosis combines a broad-panel respiratory mPCR (FilmArray Pneumonia Panel Plus (FA-PPP), BioFire Biomérieux) with conventional microbiological investigations.

Techniques: Bacteria, Biomarker Discovery